| [1] |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖和2 型糖尿病外科治疗指南(2014) [J]. 中国实用外科杂志,2014, 34(11):1005-1010.
|
| [2] |
Friedman MN, Sancetta AJ, Magovern GJ. The amelioration of diabetes mellitus following subtotal gastrectomy[J]. Surg Gynecol Obstet, 1955, 100(2):201-204.
|
| [3] |
Pories WJ, Swanson MS, MacDonald KG ,et al. Who would have thought it?an operation proves to be the most effective therapy for adult-onset diabetes mellitus[J]. Ann Surg, 1995, 222(3):339-350.
|
| [4] |
李桢,张红亚,李保东,等. Roux-en-Y 胃肠重建改善非肥胖糖尿病胃癌患者糖脂代谢[J].中华普通外科杂志, 2010, 25(1):4-8.
|
| [5] |
Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistence following weight loss surgery for morbid obesity:laparoscopic adjustable gastric banding versus laparoscopic Rouxen-Y gastric bypass[J]. Obes Surg, 2006, 16(9):1189-1197.
|
| [6] |
Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes[J]. Diabetes Care, 2009, 32(3):514-520.
|
| [7] |
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis[J]. JAMA, 2004, 292(14):1724-1737.
|
| [8] |
Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk[J].Gut,2011,60(9):1214-1223.
|
| [9] |
Ryan KK, Tremaroli V,Clemmensen C,et al. FXR is a molecular target for the effectsof vertical sleeve gastrectomy[J]. Nature, 2014,509(7499):183-188.
|
| [10] |
Vilsbøll T, Holst JJ. Incretins, insulin secretion and Type 2 diabetes mellitus[J]. Diabetologia, 2004, 47(3):357-366.
|
| [11] |
Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism[J]. Ann Surg, 2004, 240(2):236-242.
|
| [12] |
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes[J]. Ann Surg, 2006, 244(5):741-749,
|
| [13] |
Brubaker PL, Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2[J].Can J Physiol Pharmacol, 2003, 81(11):1005-1012.
|
| [14] |
Le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters[J]. Ann Surg, 2006,243(1):108-114.
|
| [15] |
Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon Like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric by pass but not adjustable gastric banding[J]. Surg Obes RelatDis, 2007, 3(6):597-601.
|
| [16] |
Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia[J].Diabetologia, 2005, 48(11):2236-2240.
|
| [17] |
Clancy TE, Moore FD, Zinner MJ. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia[J].J Gastrointest Surg, 2006, 10(8):1116-1119.
|
| [18] |
杨景哥,王存川,黄璟,等. 腹腔镜Roux-en-Y 胃旁路术治疗2 型糖尿病[J]. 南方医科大学学报, 2010, 30(6):1373-1375.
|
| [19] |
Carrodeguas L, Szomstein S, Soto F, et al. Management of gastrogastric fistulasafter divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1292consecutive patients and review of literature[J]. Surg Obes Relat Dis, 2005, 1(5):467-474.
|